Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence

Study Identifier
GMA-LTS-11-002
CT.gov Identifier
NCT01448525
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Hypotrichosis
    • Study Drug
  • bimatoprost ophthalmic solution 0.03%
  • bimatoprost vehicle solution
    • Phase
    Phase 4
    Sex
    Female
    Age
    18 - 65 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Have inadequate eyelashes * Never used prescription eyelash growth products
    Exclusion Criteria:
    * No visible eyelashes * Permanent eyeliner or eyelash implants * Semi-permanent eyelash tint, dye, or extensions within 3 months * Over-the-counter eyelash growth products within 6 months * Any disease, infection or abnormality of the eye or area around the eye * Eye surgery within 3 months, or the anticipated need for eye surgery during the study * Unable or unwilling to keep contact lenses out during drug application and for 30 minutes after application

    Protocol Summary

    The purpose of this study is to determine patient satisfaction with LATISSE® treatment for increasing eyelash prominence.

    Study Locations

    Location
    Status
    Location
    Coral Gables, Florida, United States
    Status
    Not applicable